Finder's Pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Hancock Jaffe Laboratories is a medical devices business based in the US. Hancock Jaffe Laboratories stocks (HJLI.US) are listed on the NASDAQ and all prices are listed in US Dollars. Hancock Jaffe Laboratories employs 19 staff and has a market cap (total outstanding stock value) of $98.3 million.
|52-week range||$4.99 - $11.38|
|50-day moving average||$9.02|
|200-day moving average||$6.95|
|Wall St. target price||$26.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.71|
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|1 week (2022-01-13)||N/A|
|1 month (2021-12-20)||N/A|
|3 months (2021-10-22)||-100.00%|
|6 months (2021-07-23)||-100.00%|
|1 year (2021-01-22)||-100.00%|
|2 years (2020-01-24)||-100.00%|
|3 years (2019-01-24)||-100.00%|
|5 years (2017-01-20)||N/A|
|Gross profit TTM||$-4,252,249|
|Return on assets TTM||-30.58%|
|Return on equity TTM||-55.76%|
|Market capitalisation||$98.3 million|
TTM: trailing 12 months
We're not expecting Hancock Jaffe Laboratories to pay a dividend over the next 12 months.
Hancock Jaffe Laboratories's shares were split on a 1:25 basis on 29 November 2020. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hancock Jaffe Laboratories shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hancock Jaffe Laboratories shares which in turn could have impacted Hancock Jaffe Laboratories's share price.
Over the last 12 months, Hancock Jaffe Laboratories's shares have ranged in value from as little as $4.99 up to $11.38. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hancock Jaffe Laboratories's is 1.5404. This would suggest that Hancock Jaffe Laboratories's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Hancock Jaffe Laboratories, Inc. , a medical device company, develops and sells tissue-based solutions for patients with cardiovascular disease, and peripheral arterial and venous disease in the United States and Europe. It engages in the development and manufacture of bioprosthetic medical devices for cardiovascular diseases, including the VenoValve, a porcine based device to be surgically implanted in the deep venous system of the leg to treat reflux associated with chronic venous insufficiency; and the CoreoGraft, a bovine based off the shelf conduit to be used to revascularize the heart during coronary artery bypass graft surgeries. The company was founded in 1987 and is headquartered in Irvine, California. Hancock Jaffe Laboratories, Inc. is a subsidiary of Leman Cardiovascular SA. .
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.Read more…
Review the benefits and risks of investing in these tech-focused ETFs.Read more…
We've rounded up stats on some of the most popular bicycle stocks, along with information on how they compare and how to invest. Read more…
Steps to owning and managing HAE stock, with 24-hour and historical pricing before you buy.
Use Go Auto to shop for new or used vehicles from multiple dealerships, with no hidden fees and access to bad credit financing.
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Read our expert analysis on Hifi Finance and how the token will perform in the future.
Read our expert analysis on Kusama and how the token will perform in the future.
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.